Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York City, New York, USA.
McGovern Medical School, Houston, Texas, USA.
Subst Use Misuse. 2022;57(6):995-998. doi: 10.1080/10826084.2022.2046098. Epub 2022 Mar 28.
Opioid-related Emergency Department (ED) visits have surged over the past decade. There is limited data on ED utilization patterns of patients with opioid use disorder (OUD). An improved understanding of utilization may underscore missed opportunities for screening, intervention and referral. This was a retrospective 2:1 matched case-control study conducted at a single urban ED. Cases were patients with an opioid-related index ED visit from June 1, 2017 to May 31, 2018. Controls were patients with a non-opioid related index ED visit from June 1, 2018 to May 31, 2019. The primary outcome was the association between the number of ED visits in the 24-month period surrounding the index visit (12 months prior and 12 months following) and having an opioid-related index ED visit. There were a total of 224 cases. One or more visits preceding (OR: 1.63, 95% CI: 1.17, 2.26) and following the index visit (OR: 2.69, 95% CI: 1.91, 3.78) was significantly associated with case status. Following adjustment, a higher number of visits preceding (aOR: 1.24, 95% CI: 1.08, 1.43) and following the index visit (aOR: 1.39, 95% CI: 1.23, 1.57) remained significantly associated with case status. Patients with an opioid-related index ED visit had significantly higher rates of ED utilization 12 months before and after the index visit when compared to a matched control population. These findings suggest that there are significant opportunities for ED intervention and referral to treatment both prior to and following an opioid-related ED visit in this patient population.
在过去的十年中,阿片类药物相关的急诊就诊量激增。关于患有阿片类药物使用障碍(OUD)的患者在急诊就诊的利用模式,数据有限。对利用情况的更好了解可能会突显筛查、干预和转介方面的错失机会。这是一项在单家城市急诊进行的回顾性 2:1 匹配病例对照研究。病例是 2017 年 6 月 1 日至 2018 年 5 月 31 日期间与阿片类药物相关的急诊就诊的患者。对照组是 2018 年 6 月 1 日至 2019 年 5 月 31 日期间与非阿片类药物相关的急诊就诊的患者。主要结局是在就诊前 24 个月(就诊前 12 个月和就诊后 12 个月)就诊次数与阿片类药物相关就诊之间的关联。共有 224 例病例。在就诊前(比值比 [OR]:1.63,95%置信区间 [CI]:1.17,2.26)和就诊后(OR:2.69,95%CI:1.91,3.78)的一次或多次就诊与病例状态显著相关。调整后,就诊前(调整比值比 [aOR]:1.24,95%CI:1.08,1.43)和就诊后(aOR:1.39,95%CI:1.23,1.57)的就诊次数增加与病例状态显著相关。与匹配的对照组相比,有阿片类药物相关就诊的患者在就诊前 12 个月和就诊后 12 个月的急诊就诊率明显更高。这些发现表明,在该患者群体中,在阿片类药物相关的急诊就诊前后,急诊干预和转介治疗的机会非常大。